mda-7/IL-24-Expressing Oncolytic Adenovirus Therapy (Interleukin Combinatorial Therapies)

N/A

Report date: 2025/01/26 16:25:27

Base Information

Drug Namemda-7/IL-24-Expressing Oncolytic Adenovirus Therapy (Interleukin Combinatorial Therapies)
Drug Alias NameAd.5/3-CTVCancer Terminator Virus (Interleukin Combinational Therapies/Virginia Commonwealth University)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterleukin 24 stimulants
TargetsInterleukin 24
Therapy Area/IndicationsGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInterLeukin Combinatorial Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesInterLeukin Combinatorial Therapies Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A